Dr. Reddy's Laboratories Limited (RDY) Financial Statements

Income statement

Metric	TTM	2026	2025	2024	2023
Revenue
Total Revenue	332.8B	353.5B	325.5B	279.2B	245.9B
Cost of Revenue	165.9B	167.0B	135.1B	115.6B	106.5B
Gross Profit	166.9B	186.5B	190.4B	163.6B	139.3B
Operating Expenses
R&D Expense	23.7B	25.3B	27.4B	22.9B	19.4B
SG&A Expense	110.5B	112.3B	93.9B	77.2B	68.0B
General & Admin Expense	—	—	—	—	—
Selling & Marketing Expense	—	—	—	—	—
Other Expenses	(2.5B)	—	(2.7B)	(4.2B)	(5.2B)
Total Operating Expenses	131.7B	137.7B	118.6B	95.9B	82.2B
Cost and Expenses	297.6B	304.6B	253.7B	211.4B	188.7B
Operating Income (EBIT)	35.2B	48.9B	71.8B	67.7B	57.1B
Non-Operating
Interest Income	8.5B	8.3B	2.7B	2.3B	1.2B
Interest Expense	4.2B	3.9B	2.8B	1.7B	1.4B
Net Interest Income	4.3B	4.3B	(152.0M)	567.0M	(248.0M)
Other Non-Op Income/Expense	6.2B	8.8B	4.9B	4.1B	3.2B
Non-Operating Income (excl Interest)	(4.6B)	(12.7B)	(7.8B)	(5.9B)	(4.7B)
EBT (Pre-Tax Income)	41.4B	57.7B	76.8B	71.9B	60.4B
Income Tax Expense	8.6B	13.0B	19.5B	16.2B	15.3B
Bottom Line
Net Income	33.2B	45.1B	56.5B	55.7B	45.1B
Earnings from Cont. Ops	32.8B	44.7B	57.2B	55.7B	45.1B
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	33.2B	45.1B	56.5B	55.7B	45.1B
Per Share
Basic EPS	$39.83	$53.92	$67.85	$66.80	$54.29
Diluted EPS	$39.80	$53.92	$67.77	$66.80	$54.17
Revenue Per Share	$399.72	$424.64	$390.65	$334.91	$296.18
Shares
Basic Shares Outstanding	832.7M	832.4M	833.3M	833.5M	830.2M
Diluted Shares Outstanding	832.7M	833.3M	834.3M	833.5M	831.9M
Profitability Metrics
EBITDA	55.6B	83.3B	96.7B	88.4B	74.4B
D&A	15.8B	21.7B	17.1B	14.8B	12.6B
EBIT	39.8B	61.6B	79.6B	73.6B	61.8B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026